Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
SKT961
Skin tumor tissue array, set 1, non-overlapping with SKT962, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and stages in duplicates
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$289
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Malignant melanoma of skin
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evicence of primary tumor
Tis - Melanoma in situ (Clark level I), (atypical melanocytic hyperplasia, severe melanocytic dysplasia, not an invasive malignant lesion)
T1 - Tumor 0.75 mm or less in thickness and invades the papillary dermis (Clark level II)
T2 - Tumor more than 0.75 mm but not more than 1.5 mm in thickness and or invades to the papillary-reticular dermis interface (Clark level III)
T3 Tumor more than 1.5 mm but not more than 4.0 mm in the thickness, and/or invades the reticular dermis (Clark level IV)
T3a - Tumor more than 1.5 mm but not more than 3.0 mm in thickness
T3b - Tumor more than 3.0 mm but not more than 4.0 mm in thickness
T4 - Tumor more than 4.0 mm in thickness, and/or invades subcutanesous tissue (Clark level V) and/or satellite(s) within 2 cm of the primary tumor
T4a - Tumor more than 4.0 mm in thickness and/or invades subcutanesous tissue
T4b - Satellite(s) within 2 cm of the primary tumor
Notes: in case of discrepancy between tumor thickness and level, the T category is based on the less favorable finding.
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed NO - No regional lymph node metastasis
N1 - Metastasis 3 cm or less in greatest dimension in any regional lymph node(s)
N2 - Metastasis more than 3 cm in greatest dimension in any regional lymph node(s) and/or in-transit metastasis
N2a - Metastasis more than 3 cm in greatest dimension in any regional lymph node(s)
N2b - In-transit metastasis
N2c - Both
M - Distant metastasis
MX - Distant metastasis cannot be assessed MO - No distant metastasis
M1 - Distant metastasis
M1a - Metastasis in skin or subcutaneous tissue or lymph node(s) beyond the regional lymph nodes
M1b - Visceral metastasis
Human
48
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of skin tumors.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 53 | Skin, penis | Normal skin | |||
A02 | F | 15 | Skin, leg | Normal skin | |||
A03 | M | 57 | Skin, wrist | Chronic ulcer | |||
A04 | M | 1 | Head and neck, ear | Skin polyp | |||
A05 | F | 20 | Skin, vulva | Condyloma acuminata (HPV+) | |||
A06 | M | 17 | Skin, penis | Condyloma acuminata acuminatum | |||
A07 | M | 25 | Skin | Granuloma | |||
A08 | M | 10M | Skin | Hemangioma | |||
A09 | M | 22 | Subcutaneous tissue | Neurofibroma | |||
A10 | F | 44 | Subcutaneous tissue | Neurofibroma | |||
A11 | F | 24 | Scalp, subcutaneous tissue | Neurofibroma | |||
A12 | F | 67 | Subcutaneous tissue | Fibroma | |||
B01 | M | 53 | Skin, penis | Normal skin | |||
B02 | F | 15 | Skin, leg | Normal skin | |||
B03 | M | 57 | Skin, wrist | Chronic ulcer | |||
B04 | M | 1 | Head and neck, ear | Skin polyp | |||
B05 | F | 20 | Skin, vulva | Condyloma acuminata (HPV+) | |||
B06 | M | 17 | Skin, penis | Condyloma acuminata acuminatum | |||
B07 | M | 25 | Skin | Granuloma | |||
B08 | M | 10M | Skin | Hemangioma | |||
B09 | M | 22 | Subcutaneous tissue | Neurofibroma | |||
B10 | F | 44 | Subcutaneous tissue | Neurofibroma | |||
B11 | F | 24 | Scalp, subcutaneous tissue | Neurofibroma | |||
B12 | F | 67 | Subcutaneous tissue | Fibroma | |||
C01 | M | 50 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
C02 | M | 59 | Skin, face | Squamous cell carcinoma | I | T1N0M0 | |
C03 | M | 67 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
C04 | M | 40 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
C05 | F | 62 | Skin | Squamous cell carcinoma | I | T1N0M0 | |
C06 | F | 50 | Skin, leg | Squamous cell carcinoma | I | T2N0M0 | |
C07 | M | 34 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
C08 | M | 79 | Skin | Squamous cell carcinoma | I | T2N0M0 | |
C09 | F | 53 | Skin, head | Squamous cell carcinoma | I | T1N0M0 | |
C10 | M | 47 | Skin, penis | Squamous cell carcinoma | I | T1N1M0 | |
C11 | M | 40 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
C12 | M | 71 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D01 | M | 50 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D02 | M | 59 | Skin, face | Squamous cell carcinoma | I | T1N0M0 | |
D03 | M | 67 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D04 | M | 40 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D05 | F | 62 | Skin | Squamous cell carcinoma | I | T1N0M0 | |
D06 | F | 50 | Skin, leg | Squamous cell carcinoma | I | T2N0M0 | |
D07 | M | 34 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D08 | M | 79 | Skin | Squamous cell carcinoma | I | T2N0M0 | |
D09 | F | 53 | Skin, head | Squamous cell carcinoma | I | T1N0M0 | |
D10 | M | 47 | Skin, penis | Squamous cell carcinoma | I | T1N1M0 | |
D11 | M | 40 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
D12 | M | 71 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
E01 | M | 57 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
E02 | M | 61 | Skin, head | Squamous cell carcinoma | II | T1N0M0 | |
E03 | M | 78 | Skin, face | Squamous cell carcinoma | II | T1N0M0 | |
E04 | M | 53 | Skin, trunk | Squamous cell carcinoma | II | T1N0M0 | |
E05 | M | 67 | Skin, trunk | Squamous cell carcinoma | II | T2N0M0 | |
E06 | F | 65 | Skin, vulva | Squamous cell carcinoma | II | T1N0M0 | |
E07 | M | 36 | Skin, head | Squamous cell carcinoma | II | T1N0M0 | |
E08 | M | 72 | Skin, head | Squamous cell carcinoma | III | T2N0M0 | |
E09 | M | 62 | Skin, leg | Basal cell carcinoma | T1N0M0 | ||
E10 | M | 89 | Skin, face | Basal cell carcinoma | T1N0M0 | ||
E11 | M | 80 | Skin, face | Basal cell carcinoma | T1N0M0 | ||
E12 | F | 35 | Scalp, subcutaneous tissue | Neuroendocrine carcinoma | T2N0M0 | ||
F01 | M | 57 | Skin, penis | Squamous cell carcinoma | I | T1N0M0 | |
F02 | M | 61 | Skin, head | Squamous cell carcinoma | II | T1N0M0 | |
F03 | M | 78 | Skin, face | Squamous cell carcinoma | II | T1N0M0 | |
F04 | M | 53 | Skin, trunk | Squamous cell carcinoma | II | T1N0M0 | |
F05 | M | 67 | Skin, trunk | Squamous cell carcinoma | II | T2N0M0 | |
F06 | F | 65 | Skin, vulva | Squamous cell carcinoma | II | T1N0M0 | |
F07 | M | 36 | Skin, head | Squamous cell carcinoma | II | T1N0M0 | |
F08 | M | 72 | Skin, head | Squamous cell carcinoma | III | T2N0M0 | |
F09 | M | 62 | Skin, leg | Basal cell carcinoma | T1N0M0 | ||
F10 | M | 89 | Skin, face | Basal cell carcinoma | T1N0M0 | ||
F11 | M | 80 | Skin, face | Basal cell carcinoma | T1N0M0 | ||
F12 | F | 35 | Scalp, subcutaneous tissue | Neuroendocrine carcinoma | T2N0M0 | ||
G01 | M | 62 | Lymph node, inguinal | Metastatic melanoma | |||
G02 | M | 64 | Skin, chest | Melanoma | |||
G03 | M | 60 | Skin, foot | Melanoma | |||
G04 | F | 64 | Scalp, subcutaneous tissue | Plasmacytoma | |||
G05 | F | 53 | Face, subcutaneous tissue | Fibrosarcoma? | |||
G06 | M | 44 | Chest wall, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
G07 | M | 45 | Scalp, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
G08 | F | 64 | Skin, leg, subcutaneous tissue | Malignant fibrous histiocytoma | |||
G09 | F | 41 | Trunk, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
G10 | F | 69 | Skin, neck, dermis, subcutaneous tissue | Metastatic squamous cell carcinoma of unknown site | |||
G11 | M | 56 | Skin, vulva, subcutaneous tissue | Metastatic adenocarcinoma | |||
G12 | F | 81 | Chest wall, dermis, subcutaneous tissue | Metastatic breast carcinoma | |||
H01 | M | 62 | Lymph node, inguinal | Metastatic melanoma | |||
H02 | M | 64 | Skin, chest | Melanoma | |||
H03 | M | 60 | Skin, foot | Melanoma | |||
H04 | F | 64 | Scalp, subcutaneous tissue | Plasmacytoma | |||
H05 | F | 53 | Face, subcutaneous tissue | Fibrosarcoma? | |||
H06 | M | 44 | Chest wall, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
H07 | M | 45 | Scalp, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
H08 | F | 64 | Skin, leg, subcutaneous tissue | Malignant fibrous histiocytoma | |||
H09 | F | 41 | Trunk, subcutaneous tissue | Dermatofibrosarcoma protuberans | |||
H10 | F | 69 | Skin, neck, dermis, subcutaneous tissue | Metastatic squamous cell carcinoma of unknown site | |||
H11 | M | 56 | Skin, vulva, subcutaneous tissue | Metastatic adenocarcinoma | |||
H12 | F | 81 | Chest wall, dermis, subcutaneous tissue | Metastatic breast carcinoma | |||
null |
